Anika Therapeutics, Inc.: accounts_payable
| Value | {"amount": 9074000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2022-12-31) |
| Status | current |
| Entity | Anika Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:02:51.542883+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/7255c0d7-6ce6-4e61-b0c3-6199bb4ad57e
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001171843-23-001729Retrieved: 2026-08-19T09:02:51.542883+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000898437/accounts-payable/2022-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/7255c0d7-6ce6-4e61-b0c3-6199bb4ad57e
History
- no predecessors — first report